Denovo Biopharma is a privately held biotech company providing a novel biomarker solution to personalize drug development.
Denovo Biopharma has raised $11.8M in total funding. The most recent round was Grant. The last funding was announced in April 2024.
Denovo Biopharma's investors include CICC, California Institute for Regenerative Medicine, China Resources Pharmaceutical Group, Yingke Capital, Guangzhou Yuexiu Industrial Investment Fund.
Denovo Biopharma is headquartered in San Diego, United States.
Denovo Biopharma is a privately held biotech company providing a novel biomarker solution to personalize drug development.
Denovo Biopharma is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Denovo Biopharma — Funding & Investors." VCBacked, April 30, 2024, https://www.vcbacked.co/company/denovo-biopharma. Accessed August 14, 2026.
VCBacked. (2024). Denovo Biopharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/denovo-biopharma
{{cite web |title=Denovo Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/denovo-biopharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated